Efikasi vaksin bivalen untuk pencegahan penyakit black body syndrome (BBS) pada ikan kakap putih Lates calcalifer B.
INTRODUCTION
Barramundi or Asian seabass is a commercially important aquaculture species in south-east Asia and Australia. Barramundi is widely distributed in marine, freshwater, and brackish coastal environment and is a demersal catadromous fish. Production of the fish has progressively increased in the past years (Siddik et al., 2016; Venkatachalam et al., 2018) . Other than that, new technological advances and increased demands for fish as a source of animal protein are the main reasons for the industry's growth. Expansion of the industry caused more intensive culture methods for producing higher yields (Rico et al., 2012) . Recently the sector attracted great attention and it is growing rapidly through the development of aquaculture, and intensification in the activity of barramundi fish farming increases the risk of environmental pollution that can lead to an outbreak disease (Dong et al., 2017; Kubecka et al., 2016; Sharma et al., 2012; Ransangan & Manin, 2010) . Hamed et al. (2018) stated that the appearance and development of fish diseases were the results of the interactions among pathogens, hosts, and the environment. Deteriorating environmental conditions causes new diseases popping up and causing huge losses.
In recent years an emerged disease attacks barramundi seed with clinical symptoms such as blackening body, passive movement, low appetite, bleeding in the lower abdomen, as well as liver, kidney, and the spleen of the barramundi seed turns pale caused by P. stutzeri and V. harveyi attack. This is following Ransangan and Saleem (2009) ; Ransangan et al. (2012) stated that bacterial infections caused many deaths and high losses on the culture of barramundi. The bacterial attack is inseparable from bacterial properties they have, as an example, the opportunistic bacteria such as Vibrionaceae and Pseudomonadaceae, a dominant halophilic bacteria, are pathogenic bacteria to marine organisms and also human. Assefa and Abunna (2018) mentioned that the emergence of disease outbreak could cause considerable losses in fish cultivation, thus it required effective action and appropriate bacterial disease control. The use of antibiotics cannot be tolerated because it potentially harm and it is not environmentally friendly. Ozturk and Altinok (2014) ; Wali and Balkhi (2016) stated that prevention of disease is preferable to disease treatment, both infectious and noninfectious outbreaks. Beyond that, correct diagnosis and environmentally acceptable treatment methods should be carried out. Disease prevention using fish submersion method in water and liquid antiseptic is considered ineffective, so it requires other methods to control the disease.
Vaccination is an attempt to produce specific antibody, safe and effective that can be used for the sustainable development aquaculture industry (Evensen & Leong, 2013) . In response to reduced antibiotic use in fish, production vaccines have been playing a key role in infectious disease control in aquaculture for decades. Vaccines get wide acceptance for the fact there is no risk of drug resistance development in vaccinated animals (Assefa & Abunna, 2018) . BBS caused by an infection of various bacteria such as P. stutzeri, V. harveyi, Bacillus cereus, and Salinococcus roseus. Based on the five bacteria, P. stutzeri and V. harveyi is the most pathogenic and showed clinical symptoms of BBS in the tested fish (Izwar, 2018) . Therefore, for controlling this disease should be developed a polyvalent vaccine, as well as on specifically aimed at testing the immunogenicity and protection of vaccinated barramundi.
MATERIALS AND METHODS

Time and place
The study was conducted from February 2017 to August 2017 at the Laboratory of Aquatic Organism Health, Department of Aquaculture, Faculty Fisheries and Marine Sciences, Bogor Agricultural University and the Centre for Mariculture Research Development (BBPBL) Lampung.
Fish test
Seeds of 5-6 cm barramundi fish obtained from the cultivators in the barramundi Kalianda area, South Lampung. All the fish were tested by examining the outer conditions of fish and internal organs of the fish, such as kidneys, liver, and crushed spleen then scraped into the agar medium, if there were no bacteria then the fish was safe to use. Fish was kept in aquarium size 40×40×60 cm 3 with a density of 1 fish per liter. Barramundi seed was adapted to the environmental conditions and feed for one week using commercial pellets provided at satiation.
Experimental design
This study consisted of the treatment of barramundi which was bivalent and vaccinated seeds injected by phosphate buffer saline (PBS) as control and treatment of challenge tests with single bacteria and bacteria combined. The design of the challenge test treatment is presented below in Table 1 .
Vaccine making test
The formalin-killed cell (FKC) vaccine from each of the bacteria was made by reference from Kumaran et al. (2010) . The single bacterial vaccine with each concentration of 10 9 CFU/mL was then mixed with a 50:50 ratio to get the bivalent vaccine P. stutzeri and V. harveyi. Vaccines were packed in bottles and stored in cabinets in low temperature until used.
Seed vaccination
A total of 200 barramundi seeds were injected through intraperitoneal using a 0.1 mL/ind of bivalent vaccine, while the control fish group was injected with a PBS solution of 0.1 mL/ind. The next fish was kept for 21 days.
Challenge test
The seed test was performed on the 22 nd day after vaccination with pathogenic bacteria P. stutzeri, V. harveyi, and the combination of P. stutzeri and V. harveyi using 0.1 mL with a bacterial density of 10 7 CFU/mL (corresponding to a dose of LD50) of 0.1 mL/ind. The seed was reared in an aquarium with a stocking density of 15 fish/aquarium. Mortality and RPS seeds were observed until seven days after the challenge test.
Parameter of research
The observed parameters were relative percent survival (RPS), mortality, blood profile, antibody titers, lysozyme activity, and liver histopathology.
Relative percent survival (RPS)
The calculation of RPS value was done at the end of the research to determine the effectiveness of the applied vaccine. RPS was calculated using (1988) formulation: The seed was vaccinated with bivalent vaccine and challenged with P. stutzeri
V2
The seed was vaccinated with bivalent vaccine and challenged with V. harveyi
Vg
The seed was vaccinated with bivalent vaccine and challenged with mix bacteria P. stutzeri and V. harveyi
Vk
The seed was vaccinated with bivalent vaccine and challenged with PBS
K1
The seed was injected with PBS and challenged with P. stutzeri
K2
The seed was injected with PBS and challenged with V. Harveyi
Kg
The seed was injected with PBS and challenged with mix bacteria P. stutzeri dan V. harveyi
Kk
The seed was injected with PBS and challenged with PBS
Blood view observation
The blood sample was taken from caudal fin veins. Observation of blood profile parameters consisted of erythrocyte cell counts, leukocyte count, hemoglobin, hematocrit, and phagocytic activity. Total erythrocytes and leukocyte were calculated using the method of Blaxhall and Daisley (1973) . Hemoglobin levels were measured by Sahli method (Wedemeyer & Yasutake, 1977) . The hematocrit was measured using the Anderson and Siwicki (1993) methods. Phagocytic activity was calculated based on the Anderson and Siwicki (1993) methods.
Antibody testing
Testing of antibody titer was performed on a 96-wells microplate-based on a method referred to Takahashi et al. (2014) . Measurement of antibody titer was performed by taking 25 μL of PBS solutions and put into microplate at holes 1 to 12, then inserted blood serum in the hole 1 as much as 25 μL. Series of dilution were performed from hole 1 to 11. A 25 μL of bacterins were inserted into holes 1 to 12. Furthermore, it was stored for two hours in the incubator at 37°C, followed by saving it in the 4°C refrigerator for 24 hours. The antibody titer was determined from the last remaining hole an agglutination reaction was found.
Lysozyme activity
The lysozyme activity was measured by the method by Ellis (1990) . Lysozyme activity was limited to several enzymes that caused a decrease in absorbance of 0.001/min. Here is the lysozyme calculation formula: results showed that the administration of the vaccine was effective in maintaining the survival of the barramundi infected with high pathogenicity bacteria.
The profile of barramundi seeds blood after vaccination and challenge test
The hematocrit value of day 7 after vaccination did not significantly different between all treatments (P>0.05). However, there were differences in total erythrocytes, leucocytes, hemoglobin, and phagocytic activity. Hematocrit seeds ranged from 13.10 to 15.91%. Total erythrocytes, leucocytes, hemoglobin, and phagocytic activity of barramundi seeds higher vaccine treatment compared with control and initial treatment (before vaccination) (P<0.05).
The overview blood profile of barramundi seed 21 days after vaccination is presented in Table 3 .
The blood profile of barramundi seed at seven days post-challenge between groups of fish vaccines and fish controls, each of which was tested against P. stutzeri, V. harveyi , the combination of P. stutzeri and V. harveyi , as well as the controls gave distinctly different values (P<0.05) in total erythrocytes, leucocytes, and phagocytic activity, whereas in hemoglobin values group vaccine fish treatment ranged from 11.00 to 12.00 g/dL was not significantly different (P>0.05) with control group of fish that ranged between 10.33-11.33 g/dL and hematocrit group
Data analysis
This research used a completely randomized design. All data were tabulated with Microsoft Office Excel 2013. The RPS data, blood profile, antibody titers, and lysozyme activity were analyzed using ANOVA with SPSS 24.0 at a significant level of 95%. A significant result would be analyzed further using a post-hoc Duncan›s test. Histopathology data were analyzed descriptively.
RESULTS
Mortality rate and relative percent survival (RPS) seed of barramundi
The mortality rate of barramundi seeds injected with the bivalent vaccine was significantly greater (P<0.05) than control until day 29, so did the value of RPS vaccinated fish (P<0.05) compared with the control treatment on the 29 th day of rearing. These of fish vaccine with the range of 9.81-14.29% there is no difference (P>0.05) with the control fish group in the range of 7.84-9.78% among all treatments. The blood profile barramundi of seventh-day post-banding is presented in Table 4 .
Antibody titer post-vaccination and challenge test of barramundi seed
Giving vaccine in barramundi seed had a significant effect (P<0.05) to the titer value of barramundi seed antibody during the rearing period. The antibody of vaccinated fish increased by two to four on day seventh after vaccination and significantly higher (P<0.05) than control treatment that was not increased. Provision of the vaccine in barramundi seed was also influential significant to barramundi seed antibodies tested challenge with P. stutzeri bacteria (1), V. harveyi (2), a combination of P. stutzeri and V. harveyi (g), and PBS (k). The antibody titer of each treatment is presented in Figure 1 .
Lysozyme activity of barramundi seed after vaccination and challenge test
The lysozyme activity of bivalent vaccinated seed was significantly higher on day 7 post vaccination compared with control treatment (P<0.05). Vaccine also effected the lysozyme activity of barramundi seed after the challenge test. Lysozyme activity of vaccinated fish which challenge with P. stutzeri bacteria (1), V. harveyi (2), combination of P. stutzeri and V. harveyi (g), and PBS (k) were significantly higher than the control challenge against the same bacteria. Lysozyme activity of barramundi seed after vaccination is presented in Figure 2 .
Histopathological observation
The histopathology result of barramundi fish after challenge test showed the presence of microscopic anatomical pathology difference in both treatment and control experimental fish using the combination bivalent vaccine P. stutzeri and V. harveyi (Figure 3A & 3B) . It was noticed in Figure 3A that hepatocytes was healthy and normal, whereas in Figure 3B 
DISCUSSION
Vaccination is a prevention method made from antigens derived from pathogens and made nonpathogenic through various ways which stimulates the specific immunity to control infectious diseases in fish, such as bacteria and virus attacks, and has been proven significantly in preventing disease outbreaks, and it also has low cost (Roar & Muiswinkel, 2013; Wali & Balkhi, 2016; Ayalew & Abunna, 2018; Shefat, 2018) . Health status of vaccinated fish immunity becomes one of the prove of fish health status and determine the relation with fish immune conditions before and after vaccination to demonstrate efficacy and extent protection of the vaccine (Tobar et al., 2015) . Bivalent vaccine can protect barramundi with RPS up to 80.00% when challenged with P. stutzeri bacteria, 64.29% when challenged with V. harveyi, 57.69% when challenged with combined bacteria. Mulia (2007) stated that the vaccine was considered to be effective if relative survival yields more than 50%. Results research showed that applying the bivalent vaccine was effective in protecting the barramundi seeds towards BBS. Bivalent vaccination is effective in the protection against single or combined bacterial infections. It is one of the advantages of using a multivalent vaccine. The utilization of one dose of vaccine containing many antigens affects the effectivity and reduces the stress of the fish (Shoemaker et al., 2012) .
The low mortality rate and the relatively high survival rate of vaccination treatment were generally caused by the formation of a non-specific immune response followed by specific immune enhancement. The specific immune formation was indicated by increased levels of antibodies. Besides the formation of specific immune as well as indicated by the activity of T cells (T helper cells, cytotoxic T cells, and T memory cells) and B cells (B-cell memory and cell plasma). The B cell memory would store information about the antigenic characteristics that enter the body while the cell›s plasma would produce a specific antibody to the antigen. Antigens that entered Figure 2 . Lysozyme activities of barramundi before vaccination (early), as well as on seven days post vaccination with bivalent vaccine injection (V) and control treatment the PBS (K) injection (A); Lysozime activity of barramundi seed seven days post challenges that were injected by P. stutzeri bacteria (1), V. harveyi (2), P. stutzeri and V. harveyi (g), and control (k) (B). Different superscript in each bar indicated the effect of treatment was significantly different (Duncan's P<0.05) Figure 3 . Microscopic anatomical pathology of liver tissue of barramundi on 7 th day after a combined bacterial infection of P. stutzeri and V. harveyi: A) Liver tissue of barramundi that was vaccinated and challenged test with the combined bacteria was normal and still had nucleus with normal hepatopancreas; B) Liver tissue of barramundi injected with PBS and challenge tested using combined bacteria experienced necrosis (Nk). the body was engulfed by macrophages. Once it was engulfed, the antigen will be exposed to the T helper cells through protein major histocompatibility complex (MHC) class II. The T helper cells will activate by macrophages through cytokine molecules. After being activated with cytokines from macrophages, the helper will produce cytokines that stimulate B cells, T cells memory, and cytotoxic T cells. When the identical antigen exposes for the second time, T cell memory will stimulate B cell memory to proliferate into cell plasma and produce antibody. The nonspecific immune response is indicated through the congenital body defense system and hematological parameters (Reece et al., 2014) .
The blood profile parameters have been used as indicators of health status in some species (Santos et al., 2009; Adedeji, 2010; Akinrotimi et al., 2012; Sayed & Moneeb, 2015) . One of the parameters to indicate fish health status is the total of erythrocytes. The value of erythrocytes after the challenge test was known to decrease in all treatments, especially in the control treatment. This was presumably because one of the bacteria used in the challenge test (V. harveyi) can break red blood cells so that levels of erythrocytes tend to decline. Minasyan (2014) stated that hemoglobin helps kill bacteria, that happens when erythrocytes are lysed by bacteria their hemoglobin releases free radicals which break down the pathogen's cell wall and membrane, killing it. For hematocrit, Sukenda et al. (2014) were reported that the hematocrit on vaccinated fish had no significant effect on fish health status. However, there was an effect on the total leucocytes and phagocytic activity of vaccinated fish. Results of blood profile post-vaccination still showed a normal value. However, the health status of barramundi vaccinated using the bivalent vaccine was greater than other treatments post-vaccination or after the challenge test. The result was noticed in the total leucocytes and phagocytic activity in vaccinated barramundi seed has a significantly higher value compared to control treatment. This was suspected because the antibody titer of vaccinated treatments was significantly higher than the control treatment. According to Reece et al. (2014) antibody might bind to the antigen on the surface of the bacteria cell thus it blocks the site of bacteria recognition on its host and facilitates phagocytosis. The antibody that binds to the antigens on the surface of bacteria cells is also capable of forming complexes with protein complements. These protein complements will insert into the bacterial cell membrane and form a pore which then lyses the cell target. Nonspecific body defense systems, such as phagocytic activity and lysozyme activity, also play a role in reducing the exposure of P. stutzeri and V. harveyi bacteria in the fish body.
The immune response represents the immune conditions of the fish, both specific and nonspecific immune system. The specific immunity that can show the efficacy level of the vaccine is the value of the antibody titer. The results showed that the administration of the vaccine in barramundi gives a significantly effective than unvaccinated seeds. The results of antibody titer measurements in two groups (vaccine and control) showed that there was an increase of antibody titer in the vaccinated treatment after vaccination which reached a value of 4 compared to the group of fish injected with PBS (K) during the rearing period after vaccination (day 7) ( Figure 1 ). Raida et al. (2011) stated that whole vaccines which put into the fish body intraperitoneally increased specific antibody compared to unvaccinated fish. This matter showed that vaccination was the potential to induce specific antibody responses. Sun et al. (2014) added that the application of V. harveyi vaccine was injected to Parachthys olivaceus seeds, was able to support its survival when tested using V. harveyi and S. iniae. Comparing with mortality data in Table 2 , the vaccinated group shows the lowest mortality percentages, as well as the antibody titers data (Figure 1 ). This result same to Villumsen et al. (2012) ; Romstad et al. (2013) ; Marana et al. (2017) that stated if antibody titers are related to survival rate between unvaccinated fish and vaccinated fish.
Lysozyme is a bacteriolytic enzyme produced in lysosomes in phagocyte cells, suggesting that lysozyme plays a conserved role in host defense across the animal kingdom. Lysozyme works by destroying bacterial cells via targeted hydrolysis of bacterial cell walls, which are critical for the resistance of bacteria to osmotic stress (Callewaert & Michiels, 2010; Uribe et al., 2011; Ragland & Criss, 2017) . Lysozyme activity of barramundi seed on the seventh day after vaccination between the treatment of bivalent vaccines and controls was significantly different (P<0.05). The activity of lysozyme seeds injected by the bivalent vaccine increased rapidly compared with nonvaccinated control. This was indicated by a considerable value between vaccine and control treatments on day seven after vaccination of (4.69 U/ mL (V) and 2.79 U/mL (K)). A similar thing also occurred after the challenge test. Barramundi's seed on bivalent vaccine treatment tested with P. stutzeri (1), V. harveyi (2), combined P. stutzeri and V. harveyi (g), and the control of PBS (k) had higher lysozyme activity compared with control treatments that tested against the same bacteria. The activity of lysozyme after the highest challenge test is obtained by the combined Vg (combined) treatment showed that bivalent vaccinated seeds were then tested with P. stutzeri and V. harveyi which can induce nonspecific immune systems with lysozyme values of 193.79 U/mL. It was suggested that vaccination did not only improve specific immune responses but also enhances nonspecific immune. The utilization of the bivalent vaccine in barramundi's seed also affected the condition of microscopic internal organs. Figure 3A showed the liver organ of the bivalent combination vaccine had plenty of normal and healthy hepatocyte cells at 7 th the challenge test, while Figure 3B is the treatment of fish seed injected by PBS and tested against combined bacteria. Both of them took on the same day and of the two there are differences with the number of necrotic hepatocyte cells. The result of research from El-Sharaby et al. (2018) , are known that the histopathological examination of the livers naturally infected fishes by Vibrio showed necrosis of hepatocytes, necrotic means the death of cells or tissues caused by diseases. Healthy liver cells in Figure 3A showed that bivalent vaccines can protect fish from necrotic cells and mortality.
CONCLUSION
Bivalent vaccines were effective in controlling BBS disease in terms of the value of RPS on all treatments which was more than 50%. The bivalent vaccine of P. stutzeri and V. harveyi bacteria potentially protected the barramundi seed to prevent BBS disease outbreak.
